|6.06||-0.07 / -1.14%|
As of 4:04pm ET
|6.10||+0.0401 / +0.66%|
The 4 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 14.00, with a high estimate of 30.00 and a low estimate of 10.00. The median estimate represents a +131.02% increase from the last price of 6.06.
The current consensus among 4 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.